NRP1 and breast cancer: Since breast cancer metastasis is the main cause of patient death [10], and the lungs are the primary site of metastases, particularly for patients with triple-negative breast cancer [11], we aimed to functionally inactivate NRP-1 in triple-negative breast cancer cells and study the impact on their metastatic potential.